Nuveen Asset Management, LLC Biotechnology

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ALXO Alx Oncology Holdings Inc	$22.4M	$275,000 0.0% of portfolio	164,790	Q4 2024 Added 55.62%
IGMS Igm Biosciences, Inc.	$35.3M	$275,000 0.0% of portfolio	45,015	Q3 2024 Added 10.47%
LCTX Lineage Cell Therapeutics, Inc.	$69.6M	$257,000 0.0% of portfolio	515,445	Q2 2023 New
BMEA Biomea Fusion, Inc.	$49.5M	$255,000 0.0% of portfolio	65,803	Q2 2024 Added 19.24%
PBYI Puma Biotechnology, Inc.	$130M	$241,000 0.0% of portfolio	79,101	Q4 2024 Added 41.45%
APLT Applied Therapeutics Inc.	$15.8M	$238,000 0.0% of portfolio	281,028	Q4 2024 Added 7.5%
TCRX T Scan Therapeutics, Inc.	$27.3M	$211,000 0.0% of portfolio	69,962	Q2 2024 New
PYXS Pyxis Oncology, Inc.	$33.7M	$197,000 0.0% of portfolio	127,304	Q4 2024 Reduced 14.57%
ATNM Actinium Pharmaceuticals, Inc.	$30.5M	$187,000 0.0% of portfolio	148,560	Q4 2024 Added 49.54%
RAPT Rapt Therapeutics, Inc.	$23.4M	$184,000 0.0% of portfolio	116,925	Q4 2024 Added 50.47%
GBIO Generation Bio Co.	$23M	$179,000 0.0% of portfolio	169,265	Q1 2024 Reduced 26.07%
FENC Fennec Pharmaceuticals Inc.	$132M	$164,000 0.0% of portfolio	26,006	Q1 2024 Added 6.32%
ATOS Atossa Therapeutics, Inc.	$78.5M	$160,000 0.0% of portfolio	170,733	Q2 2024 New
ELYM Eliem Therapeutics, Inc.	$109M	$160,000 0.0% of portfolio	39,034	Q3 2024 New
IPSC Century Therapeutics, Inc.	$31.8M	$158,000 0.0% of portfolio	157,311	Q4 2024 Added 48.9%
RGLS Regulus Therapeutics Inc.	$30.1M	$135,000 0.0% of portfolio	85,602	Q2 2024 New
ABOS Acumen Pharmaceuticals, Inc.	$36.5M	$134,000 0.0% of portfolio	78,446	Q3 2024 Added 38.44%
CHRS Coherus Bio Sciences, Inc.	$87.1M	$131,000 0.0% of portfolio	95,056	Q1 2024 Reduced 87.51%
VERU Veru Inc.	$42.5M	$116,000 0.0% of portfolio	178,557	Q2 2024 New
OVID Ovid Therapeutics Inc.	$20.4M	$110,000 0.0% of portfolio	119,113	Q1 2024 Added 4.41%
PEPG Pep Gen Inc.	$31.4M	$108,000 0.0% of portfolio	28,557	Q2 2024 Added 106.22%
HOWL Werewolf Therapeutics, Inc.	$27.2M	$108,000 0.0% of portfolio	73,370	Q3 2024 Added 40.97%
AVTE Aerovate Therapeutics, Inc.	$67.2M	$106,000 0.0% of portfolio	40,047	Q4 2023 Added 10.29%
ELEV Elevation Oncology, Inc.	$9.09M	$100,000 0.0% of portfolio	174,137	Q3 2024 Added 114.49%
XBIT X Biotech Inc.	$89.5M	$98,000 0.0% of portfolio	24,879	Q2 2024 New
INMB Inmune Bio, Inc.	$131M	$77,000 0.0% of portfolio	16,518	Q2 2024 New
STTK Shattuck Labs, Inc.	$32.6M	$64,000 0.0% of portfolio	53,038	Q2 2024 New
GALT Galectin Therapeutics Inc	$82M	$32,000 0.0% of portfolio	27,623	Q2 2024 New
PRLD Prelude Therapeutics Inc	$29.5M	$21,000 0.0% of portfolio	16,797	Q4 2023 Added 21.68%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	157,951	Q3 2024 Added 2.28%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.